113 related articles for article (PubMed ID: 8597590)
1. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.
Dentan C; Tselepis AD; Chapman MJ; Ninio E
Biochim Biophys Acta; 1996 Feb; 1299(3):353-7. PubMed ID: 8597590
[TBL] [Abstract][Full Text] [Related]
2. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid.
Seo HS; Kim JH; Nahm MH
Clin Vaccine Immunol; 2006 Apr; 13(4):452-8. PubMed ID: 16603612
[TBL] [Abstract][Full Text] [Related]
4. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
5. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis.
Chen J; Yang L; Foulks JM; Weyrich AS; Marathe GK; McIntyre TM
J Lipid Res; 2007 Nov; 48(11):2365-76. PubMed ID: 17693621
[TBL] [Abstract][Full Text] [Related]
6. Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.
Touqui L; Hatmi M; Vargaftig BB
Biochem J; 1985 Aug; 229(3):811-6. PubMed ID: 4052028
[TBL] [Abstract][Full Text] [Related]
7. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation.
Goyal J; Wang K; Liu M; Subbaiah PV
J Biol Chem; 1997 Jun; 272(26):16231-9. PubMed ID: 9195924
[TBL] [Abstract][Full Text] [Related]
8. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
Satoh K; Imaizumi T; Yoshida H; Takamatsu S
J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.
Carpenter KL; Dennis IF; Challis IR; Osborn DP; Macphee CH; Leake DS; Arends MJ; Mitchinson MJ
FEBS Lett; 2001 Sep; 505(3):357-63. PubMed ID: 11576528
[TBL] [Abstract][Full Text] [Related]
11. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
12. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
Dentan C; Lesnik P; Chapman MJ; Ninio E
Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase.
Palmantier R; Dulioust A; Maiza H; Benveniste J; Ninio E
Biochem Biophys Res Commun; 1989 Jul; 162(1):475-82. PubMed ID: 2751666
[TBL] [Abstract][Full Text] [Related]
15. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
17. Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.
Korth R; Bidault J; Palmantier R; Benveniste J; Ninio E
Lipids; 1993 Mar; 28(3):193-9. PubMed ID: 8464350
[TBL] [Abstract][Full Text] [Related]
18. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
Pritchard PH; Chonn A; Yeung CC
Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
[TBL] [Abstract][Full Text] [Related]
19. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions.
Pellon MI; Fernandez-Gallardo S; Gijon MA; Garcia MC; Liu FT; Sanchez Crespo M
Immunopharmacology; 1993; 26(1):73-82. PubMed ID: 8407286
[TBL] [Abstract][Full Text] [Related]
20. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells.
Neuwirth R; Ardaillou N; Schlondorff D
Am J Physiol; 1989 Apr; 256(4 Pt 2):F735-41. PubMed ID: 2705543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
